Buys
Open market- Shares
- +161,801
- Avg price
- $0.8994
- Total value
- +$145,526
Lynx1 Capital Management LP - 10%+ Owner at TScan Therapeutics, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- TCRX on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Lynx1 Capital Management LP in TScan Therapeutics, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +161,801
- Share %
- 100%
- Total value
- +$145,526
Reported holdings for Lynx1 Capital Management LP in TScan Therapeutics, Inc.
Form 4 holding
10%+ Owner
TScan Therapeutics, Inc.
- Security class
- Pre-funded Warrant (right to buy)
- Shares / value
- 7,500,000
- Estimated value
- $30,000,000
- Report date
- 26 Dec 2024
- Price
- $4.00
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
TScan Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 8,019,148
- Estimated value
- $7,208,412
- Report date
- 23 Dec 2025
- Price
- $0.8989
- Ownership
- Indirect
Transaction history for Lynx1 Capital Management LP in TScan Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.